Literature DB >> 27052211

Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.

Adisak Tantiworawit1, Pimlak Charoenkwan2, Sasinee Hantrakool1, Worawut Choeyprasert3, Chate Sivasomboon4, Torpong Sanguansermsri3.   

Abstract

In the present study, we sought to determine the prevalence of iron overload in patients with non-transfusion-dependent thalassemia (NTDT) and its association with genotype and other clinical risk factors, and to evaluate the correlation between serum ferritin (SF) and liver iron concentration (LIC). Myocardial and liver iron concentration was measured by MRI using a T2* gradient multi-echo sequence in NTDT patients, aged 10-50 years. Of 91 patients, 54 (59 %) had hepatic iron overload. None had cardiac iron overload. The clinical risk factors for hepatic iron overload were age >20 years (adjusted OR 30.2, 95 % CI 4.5-203, p < 0.001), hemoglobin level <7 g/dL (adjusted OR 6.3, 95 % CI 1.01-39.5, p = 0.049), and cumulative RBC transfusion >10 units (adjusted OR 53.6, 95 % CI 3.2-884, p = 0.005). Beta-thalassemia genotype was associated with higher risk of iron overload by univariate analysis, but the association was not significant when adjusted for other clinical factors. The correlation coefficient between SF and LIC was 0.60 (p < 0.001). In conclusion, the prevalence of hepatic iron overload is high in NTDT. Older age, lower hemoglobin level, and higher cumulative RBC transfusion are significant risk factors. SF and LIC show a significant positive correlation.

Entities:  

Keywords:  Ferritin; Genotype; Iron overload; Liver iron concentration; Non-transfusion-dependent thalassemia; Prevalence; Risk factor

Mesh:

Substances:

Year:  2016        PMID: 27052211     DOI: 10.1007/s12185-016-1991-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Age-related complications in treatment-naïve patients with thalassaemia intermedia.

Authors:  Ali T Taher; Khaled M Musallam; Amal El-Beshlawy; Mehran Karimi; Shahina Daar; Khawla Belhoul; Mohamed-Salaheldin Saned; Giovanna Graziadei; Maria D Cappellini
Journal:  Br J Haematol       Date:  2010-04-29       Impact factor: 6.998

3.  Effect of genotype on pulmonary hypertension risk in patients with thalassemia.

Authors:  Nattiya Teawtrakul; Phuangpaka Ungprasert; Burabha Pussadhamma; Patcharawadee Prayalaw; Supan Fucharoen; Arunee Jetsrisuparb; Saranya Pongudom; Chittima Sirijerachai; Kanchana Chansung; Chinadol Wanitpongpun; Suporn Chuncharunee
Journal:  Eur J Haematol       Date:  2014-01-30       Impact factor: 2.997

Review 4.  Optimal management of β thalassaemia intermedia.

Authors:  Ali T Taher; Khaled M Musallam; Maria Domenica Cappellini; David J Weatherall
Journal:  Br J Haematol       Date:  2011-01-20       Impact factor: 6.998

5.  Iron overload in Beta thalassaemia major and intermedia patients.

Authors:  Amit Kumar Mishra; Archana Tiwari
Journal:  Maedica (Buchar)       Date:  2013-09

Review 6.  Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.

Authors:  Khaled M Musallam; Maria D Cappellini; John C Wood; Ali T Taher
Journal:  Blood Rev       Date:  2012-04       Impact factor: 8.250

Review 7.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

8.  Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Ali T Taher; John Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Jacqueline Ros; Yiyun Zhang; Dany Habr; Maria Domenica Cappellini
Journal:  Blood       Date:  2012-05-15       Impact factor: 22.113

9.  Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.

Authors:  Thomas V Adamkiewicz; Miguel R Abboud; Carole Paley; Nancy Olivieri; Melanie Kirby-Allen; Elliott Vichinsky; James F Casella; Ofelia A Alvarez; Julio C Barredo; Margaret T Lee; Rathi V Iyer; Abdullah Kutlar; Kathleen M McKie; Virgil McKie; Nadine Odo; Beatrice Gee; Janet L Kwiatkowski; Gerald M Woods; Thomas Coates; Winfred Wang; Robert J Adams
Journal:  Blood       Date:  2009-08-31       Impact factor: 22.113

Review 10.  The definition and epidemiology of non-transfusion-dependent thalassemia.

Authors:  David J Weatherall
Journal:  Blood Rev       Date:  2012-04       Impact factor: 8.250

View more
  5 in total

Review 1.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

Review 2.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

3.  Correlation of Liver and Myocardium Iron Concentration Determined by Magnetic Resonance Imaging With Serum Ferritin in Non-Transfusion-Dependent Thalassemia Patients.

Authors:  Nagenthran Gayathri; M Vasantha Kumar; Thangam Vinoth; Radhan Prabhu; S Krishnabharath
Journal:  Cureus       Date:  2022-07-29

4.  Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.

Authors:  João Arezes; Niall Foy; Kirsty McHugh; Doris Quinkert; Susan Benard; Anagha Sawant; Joe N Frost; Andrew E Armitage; Sant-Rayn Pasricha; Pei Jin Lim; May S Tam; Edward Lavallie; Debra D Pittman; Orla Cunningham; Matthew Lambert; John E Murphy; Simon J Draper; Reema Jasuja; Hal Drakesmith
Journal:  Blood       Date:  2020-02-20       Impact factor: 25.476

5.  Iron overload status in patients with non-transfusion-dependent thalassemia in China.

Authors:  Yumei Huang; Gaohui Yang; Man Wang; Xiaoyun Wei; Lingyuan Pan; Jiaodi Liu; Yu Lei; Liling Long; Yongrong Lai; Rongrong Liu
Journal:  Ther Adv Hematol       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.